Live news related to MEDINCELL stock (FR0004065605): press releases, earnings publications, share price moves, analyst notes and corporate events. This page is auto-updated whenever new financial information is available.
The biotechnology lab's stock shows a pronounced decline at the end of the session, resulting from profit-taking after two months of strong accumulati…
MEDINCELL stock has made a notable advance over the past five sessions, starkly contrasting with the negative trend of the Parisian market. While the …
MedinCell closed Tuesday, October 28, with a gain, reaching 37.12 euros. The French biotech company, specializing in extended-release injectable formu…
This week, Medincell's upward momentum continued in the markets, with the stock now reaching new highs. The share is significantly advancing amid sust…
MEDINCELL closes the week in a strong position. The stock of the Paris-based biotech company reached 36.00 EUR at Friday's close, boosted by a daily i…
The stock of French biotech company MedinCell continues its upward trend this Thursday, October 23, at midday. At EUR 34.70, the stock has gained 2.54…
Medincell, a biopharmaceutical licensing company, will participate in the Truist Securities Biopharma Symposium 2025 in New York to discuss its strate…
On this Monday, October 20th, the biopharmaceutical company MedinCell's stock shows a mid-session increase of 2.01%, reaching 34.58 euros compared to …
This week, Medincell's stock stood out at the top of the SBF 120 with significant growth. The lab's technology benefited from a major regulatory endor…
The stock closed up 2.62% on Thursday, extending the bullish movement that began a week ago.
